Imovane (Zopiclone)

Zopiclone binds to the benzodiazepine site on GABA‑A receptors as a positive allosteric modulator. By enhancing the natural inhibitory action of GABA, it reduces neuronal excitability in the brain, which promotes the onset of sleep and helps maintain sleep throughout the night.

The appropriate dose of Imovane is determined by a qualified prescriber based on the individual’s age, health status, and response to therapy. Physicians typically start with the lowest effective dose and adjust as needed, while keeping treatment duration as short as clinically appropriate.

Safety data for Zopiclone in pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternative sleep‑management strategies with their healthcare provider.

To order Imovane, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imovane (Zopiclone) belongs to the cyclopyrrolone class, whereas many other hypnotics, such as temazepam, are benzodiazepines. Both promote sleep, but Zopiclone has a slightly different receptor binding profile and may be associated with a lower risk of certain withdrawal symptoms, though individual response varies.

Imovane tablets should be stored at ambient temperature, below 25 °C, in their original container to protect them from moisture and light. Keep the medication out of reach of children and avoid storing it in bathrooms or other humid environments.

Imovane is taken orally, usually with a glass of water, just before bedtime. It should be taken only when the patient can allow for a full night’s sleep (7–8 hours) and should not be combined with alcohol or other central nervous system depressants.

Serious risks include complex sleep behaviours such as sleep‑walking or sleep‑driving, severe allergic reactions (rash, swelling, breathing difficulty), and mood changes like depression or suicidal thoughts. If any of these occur, immediate medical attention is required.

Imovane should be avoided in patients with known hypersensitivity to Zopiclone, severe hepatic impairment, a history of substance misuse, or those who are unable to stay in bed for a full night’s sleep. Caution is also advised for individuals with untreated sleep‑apnoea or severe respiratory disorders.